Epidemiological data reveal a significant global rise in metabolic dysfunction-associated steatotic liver disease ( MASLD ) among pediatric patients. Recent research underscores key management principles, including early screening and lifestyle interventions, tailored to the unique needs of children and adolescents. Clinicians face increasing urgency to adapt strategies for this metabolic epidemic. To read more Click Here ##Reference## Schwimmer JB, Biddinger SB, Ibrahim SH.
MASLD in children: integrating epidemiological trends with mechanistic and translational advances. J Clin Invest. 2025;135(13):e186422..## Which intervention is critical for addressing pediatric MASLD? a) Early lifestyle counseling b) Immediate pharmacotherapy c) Routine liver biopsy d) Universal supplementation
